Pure Global: Dubai's AI Surgical Tech Rush & Cracking MOHAP's Secret Corridors.

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Pure Global: Dubai's AI Surgical Tech Rush & Cracking MOHAP's Secret Corridors.

Listen for free

View show details

Last week, the UAE's Ministry of Health and Prevention (MOHAP) launched a game-changing "fast-track corridor" for AI-powered medical devices in partnership with a major industry player. This move signals a seismic shift in the region's regulatory landscape, creating a potential gold rush for innovative firms while raising the barrier to entry for others. This episode of MENA MedTech Insights unpacks what this new strategic partnership means for your business. We go beyond the headlines to explore the specific requirements of this new pathway, the opportunities for companies with cutting-edge surgical and diagnostic AI, and the potential pitfalls of navigating this exclusive new channel. Consider this: your firm has a revolutionary AI-powered diagnostic tool with full CE marking, but is that enough to get you into Dubai's new fast-track program. How do you navigate the unwritten rules and prove your technology aligns with the UAE's long-term healthcare vision before your competitors do. Key questions from this episode: - What specific device categories are being prioritized in the UAE's new AI regulatory corridor. - How can companies without a direct partnership still leverage this new initiative. - What are the key differences between a standard MOHAP submission and the new fast-track data requirements. - How do local data privacy laws in the UAE impact AI MedTech approvals. - What are the three critical steps to prepare your dossier for this new pathway. - Is this new corridor a sign of wider regulatory harmonization in the GCC. Struggling to keep up with regulatory shifts in the MENA region. Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, combining local expertise with advanced AI to streamline global market access. Let us be your local representative and guide your market entry strategy. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to learn more.

No reviews yet